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Abstract 
Sixty-nine years separated the first observation of Cryptosporidium by Tyzzer in 1907 
from the realisation in 1976 that this enteric protozoan parasite was pathogenic. It is the 
third major cause of diarrhoeal disease worldwide causing a self-limiting infection in 
immuno-competent humans and young vertebrates. As yet there is no antimicrobial 
agent that combats Cryptosporidium so the organism poses a life threatening risk to the 
immuno-compromised e.g., AIDS patients, patients on immuno-suppressive drugs, 
chemotherapy or congenital immune deficiencies. By 2000 AD 152 species of mammals 
had been reported as being infected with Cryptosporidium plus 57 reptilian species and 
many birds and fish. 
The advent of AIDS stimulated research into Cryptosporidium resulting in the large 
amount of information now becoming available, however little is known about the 
genetic characteristics, distribution and transmission cycles of Cryptosporidium species 
that cause human disease in New Zealand. To address these questions 1613 animal 
faecal samples and 423 human faecal specimens containing Cryptosporidium oocysts 
were collected from throughout New Zealand and examined by the polymerase chain 
reaction restriction fragment length polymorphism technique (PCR-RFLP). 
Indeterminant results were resolved by DNA sequence analysis of the small subunit 
ribosomal DNA (rDNA). 
Only 2.8% of the animal faecal specimens contained oocysts with the vast majority of 
these being C. parvum bovine genotype from calves. 
Two regions supplied the majority of human isolates, one rural and one urban. Overall 
C. hominis accounted for 47% of all human isolates with the remaining 53% being C. 
parvum bovine genotype. A difference however, was observed between the 
Cryptosporidium species from rural and urban isolates with C. hominis dominant in the 
urban region while C. parvum bovine genotype was prevalent in rural New Zealand. A 
shift in transmission cycles was detected between seasons with an anthroponotic cycle in 
autumn and a zoonotic cycle in spring. A novel Cryptosporidium, that on DNA sequence 
analysis showed a close relationship with C. canis, was detected in two unrelated 
children from different regions, illustrating the genetic diversity within this genus. 
II 
Acknowledgements 
As with any research of this nature and performed over a lengthy period there are many 
people to acknowledge, most of them inadequately. Those mentioned below played a 
major part in the completion of this project and hopefully persons not included in these 
acknowledgements will forgive me for the oversight. 
Professor Tim Brown started me on the journey, providing every encouragement before 
handing over the reins to my supervisor Dr. George Ionas. George supported me with 
helpful suggestions, gave me the time to carry out the research and continued to secure 
contracts from the New Zealand Ministry of Health, which enabled me to keep my head 
above water. Thanks go to past and present members of the Protozoa Research Unit and 
MicroAquaTech; Liz Keys, Trish McLenachan, Kim Ebbett, Errol Kwan, Anthony Pita 
and Rebecca Pattison, all of whom endured my black moments and kept on smiling. 
Kim rolled her sleeves up and helped me sift through many specimens. If Tim started 
the voyage thanks go to Glenda Shaw who finished it with her own special style of 
verbal repetitive commands, ordering me to get on and finish writing. 
I well remember going to my first lecture in more years then I am willing to admit to, 
with Liz Keys. It was a DNA Technology lecture given by the inspiration educator Dr. 
Stowell, who started the lecture with "we will not have to go over this point as we 
covered it last year" - it was to become a recurring theme. I really wondered at times at 
what I was doing there, as must have the ever patient Dr. Stowell. 
Collection of the human faecal specimens was carried out by a great many medical 
laboratory scientists from throughout New Zealand but special thanks go to Jan Bird, 
who at the time worked for MedLab Hamilton and Vicky McKnight from Medical 
Laboratory Wellington. Karen Cooper of Gribbles Veterinary Pathology diligently 
collected animal faecal specimens over many months, allowing me access to many 
potential Cryptosporidium hosts that I could not have otherwise examined. To collect 
positive faecal specimens and send them to the PRU takes a considerable effort when 
working in a busy diagnostic laboratory and I thank them all. Without Dr. Padraig 
Duignan I could not have searched through the faecal specimens from his collection of 
Ill 
marine mammals. Positive horse samples came courtesy of Alex Grinberg also from 
IV ABS. Hopefully all the faecal suppliers will have learnt a little more of the nature of 
Cryptosporidium from this work. 
The perpetually busy Ina Te Wiata, who coincidentally was working with 
Cryptosporidium in the mid 1970s when the pathogenicity of the organism was being 
debated, helpfully proofread the thesis . Her many helpful comments were incorporated 
into this document. 
Finally I must thank my family for their support and words of encouragement; Heather 
who in the early stages of this project provided me with food, drink, time and space in 
which to work, Richard for his good humour, Andrew for his understanding (having just 
handed in his own Master's thesis) and Peter who will finally get the computer back so 
that he may "clock" whichever game is currently all the rage amongst his age group. 
IV 
Table of Contents PAGE 
Abstract ii 
Acknowledgements iii 
Table of Contents V 
List of Figures ix 
List of Tables xi 
Chapter One: Detection, Isolation, Viability and Genetic Characterisation 1 
1.1 Cryptosporidium - Background 
1.1.1 History 
1.1.2 Biology 
1.1.3 Taxonomy 
1.2 Cryptosporidium Genome 
1.2.1 Molecular genetics 
1.2.2 Ribosomal gene organisation 
1.3 Oocyst Detection 
1.4 
1.5 
1.3.1 Acid-fast staining 
1.3.2 Immunological detection 
1.3.3 Polymerase chain reaction (PCR) techniques 
Oocyst Recovery 
1.4.1 Flotation techniques 
1.4.2 Flow Cytometry 
1.4.3 Immunomagnetic separation (IMS) 
Viability 
1.5.1 Fluorogenic vital dyes 
1.5.2 Tissue culture infectivity 
1.5.3 Animal infectivity 
1.5.4 Excystation and genetic analysis 
1.5.5 Reverse transcription-PCR of messenger RNA 
1 
1 
1 
2 
4 
4 
5 
6 
6 
6 
7 
9 
9 
10 
11 
12 
13 
13 
14 
14 
14 
V 
1.6 Molecular Characterisation of Cryptosporidium 
1.6.1 Nucleic acid extraction 
1.6.2 Random amplified polymorphic DNA analysis 
1.6.3 Sequencing and/or PCR-restriction fragment length 
polymorphism analysis 
1.6.4 Microsatellites 
1.6.5 Single nucleotide polymorphisms 
1.6.6 Viral-like double-stranded RNA 
1.7 Objectives and Approaches 
Chapter Two: Materials and Methods 
2.1 Collection of Cryptosporidium Oocysts 
2.1.1 Oocyst collection from dairy farms 
2.1.2 Oocyst collection from medical diagnostic laboratories 
15 
15 
16 
16 
18 
19 
19 
20 
22 
22 
22 
22 
2.1.3 Oocyst collection from veterinary diagnostic laboratories 23 
2.2 Detection of Cryptosporidium Oocysts 24 
2.2.1 Modified Ziehl-Nelseen's acid-fast stain 24 
2.2.2 Direct irnmunofluorescent antibody stain 25 
2.2.3 Differential interference contrast microscopy 27 
2.3 Isolation of Cryptosporidium Oocysts 28 
2.3.1 Oocyst concentration 28 
2.3.2 Irnmunomagnetic separation 28 
2.4 Extraction of Nucleic Acid from Cryptosporidium Oocysts 30 
2.5 
2.4.1 Nucleic acid extraction 
PCR Amplification of Cryptosporidium Loci 
2.5.1 PCR amplification of a generic Cryptosporidium locus 
2.5.1.1 Purification, quantitation and sequencing 
of the PCR products 
2.5.2 PCR amplification of specific Cryptosporidium loci 
2.5.2.1 ITS-1 PCR and RFLP 
2.5.2.2 
2.5.2.3 
2.5.2.4 
2.5.2.5 
18S rDNA PCR and RFLP 
~-tubulin PCR and RFLP 
Poly-T PCR and RFLP 
COWP PCR and RFLP 
30 
31 
31 
34 
36 
36 
39 
43 
45 
47 
VI 
2.6 
2.7 
2.5.2.6 RNR Rl PCR and RFLP 
2.5.3 PCR sensitivity of specific Cryptosporidium loci 
RT-PCR of Viral-Like dsRNA 
2.6.1 dsRNA purification 
2.6.2 dsRN A RT-PCR 
Data Analysis 
2.7.1 Alignment of Cryptosporidium DNA sequences 
2.7.2 Phylogenetic analysis of aligned Cryptosporidium 
DNA sequences 
2.7.3 Nucleotide sequence accession numbers 
Chapter 3: Results 
3.1 
3.2 
3.3 
3.4 
Comparison of staining techniques 
Speciating/genotyping Cryptosporidium isolates at various loci 
3.2.1 ITS-1 rDNA PCR-RFLP 
3.2.2 18S rDNA PCR-RFLP 
3.2.3 ~-tubulin PCR-RFLP 
3.2.4 Additional loci examined 
Data analysis 
3.3.1 Cryptosporidium species geographic distribution 
3.3.2 Cryptosporidium species seasonality 
Cryptosporidium species subgenotyping 
Chapter 4: Discussion 
4.1 Cryptosporidium species isolated from animals 
4.2 Cryptosporidium species isolated from humans 
4.3 Virus-like, small dsRNA sub-genotyping 
4.4 Summary and future directions 
49 
51 
51 
51 
52 
56 
56 
56 
57 
58 
58 
59 
60 
65 
69 
71 
73 
73 
74 
75 
78 
78 
79 
82 
83 
vii 
Appendices 85 
Appendix A: Abbreviations 85 
Appendix B: Sequence data 88 
Appendix B (i) Multiple 18S rDNA sequence alignment 88 
Appendix B (ii) Multiple viral-like dsRNA sequence alignment 94 
Appendix B (iii) 18S rDNA evolutionary genetic distances 97 
References 98 
Publications 118 
1. Learmonth, J. J., G. Ionas, A. B. Pita, and R. S. Cowie. 2003. 
Identification and genetic characterisation of Giardia and 
Cryptosporidium strains in humans and dairy cattle in the Waikato region 
of New Zealand. Water Science and Technology 47:21-26. 
2. Grinberg, A., L. Oliver, J. J. Learmonth, M. Leyland, W. Roe, and W. 
Pomroy. 2003. Identification of Cryptosporidium parvum "cattle" 
genotype from a severe outbreak of neonatal foal diarrhoea. The 
Veterinary Record 153:628-631 . 
3. Learmonth, J. J., G. Ionas, K. A. Ebbett, and E. S. Kwan. 2004. Genetic 
Characterization and Transmission Cycles of Cryptosporidium Species 
Isolated from Humans in New Zealand. Appl. Environ. Microbiol. 
70:3973-3978. 
viii 
List of Figures 
Figure 1. Coupling of biotinylated Cryptosporidium monoclonal 
antibody to streptavidin coated paramagnetic beads. 
Figure 2. DFA (A) and modified ZN (B) of the same Cryptosporidium 
positive faecal sample at 640X magnification. 
Figure 3. Normaski DIC photomicrograph of viable C. hominis 
oocysts after IMS isolation. 800X magnification. 
Figure 4. C. parvum KSU-1 (bovine genotype) and C. hominis 
GenBank AF 090312 aligned partial rRNA gene sequences. 
Figure 5. ITS-1 rDNA PCR of human and bovine faecal 
Cryptosporidium isolates . 
Figure 6. PCR-RFLP gel of ITS-1 rDNA digested with Dral. 
Figure 7. C. hominis [GenBank AF108865] and C. parvum bovine 
genotype [GenBank AF 108864] aligned 18S rDNA 
gene sequences. 
Figure 8. 18S rDNA PCR of human and bovine Cryptosporidium isolates. 
Figure 9. Cryptosporidium species diagnosis by Vsp 1 (A) and Ssp 1 
(B) endonuclease restriction digestion of nested PCR 18S rDNA. 
Figure 10. Multiple DNA sequence alignment, including the novel 
isolates 2683 and 2893, through a polymorphic region of 
the Cryptosporidium 18S rDNA. 
Figure 11. Neighbour-joining tree analysis of Cryptosporidium 
18S rDNA, showing the phylogenetic relationship of New 
Zealand isolates to Cryptosporidium species retrieved 
from GenBank. 
29 
58 
59 
61 
62 
63 
66 
67 
67 
68 
70 
IX 
Figure 12. PCR-RFLP gels of ~-tubulin, Poly T, RNR and COWP loci. 72 
Figure 13. Seasonal changes in the transmission cycle of 
Cryptosporidium sp. isolated from humans. 75 
Figure 14. RT-PCR of the dsRNA from three Cryptosporidium isolates. 76 
Figure 15. Phylogenetic tree inferred by neighbour joining analysis 
of dsRNA nucleotide sequences. 77 
Figure 16. National monthly numbers of cryptosporidiosis cases 
notified to the New Zealand Ministry of Health since 
July 1996. 81 
X 
List of Tables 
Table 1. Described species of Cryptosporidium. 3 
Table 2. Recovery efficiency of the USEPA and IMS methods. 10 
Table 3. Length and percentage AT richness of the ITS-1 and 
ITS-2 rDNA regions of Cryptosporidium isolates from 
different hosts. 17 
Table 4. Amplicon lengths and Dral restriction fragment sizes for the 
ITS-1 region of Cryptosporidium isolates from different hosts. 18 
Table 5. Medical diagnostic laboratories participating in a nationwide 
survey of Cryptosporidium species infecting humans in 
New Zealand. 23 
Table 6. Veterinary and animal diagnostic laboratories which referred 
specimens for Cryptosporidium species detection. 24 
Table 7. PCR sensitivity at six different loci. 60 
Table 8. Total number of faecal samples tested by DF A for the presence 
of Cryptosporidium oocysts from various hosts . Positive 
samples were speciated by ITS-1 PCR-RFLP. 64 
Table 9. Total number of faecal samples tested by DF A for the presence 
of Cryptosporidium oocysts from various hosts. Positive 
samples were speciated by either 18S rDNA PCR-RFLP and 
direct sequencing or ~-tubulin PCR-RFLP. 71 
Table 10. Restriction endonuclease digestion fragment sizes (bp) at six loci. 73 
Table 11. Geographic distribution of Cryptosporidium species from 
New Zealand human isolates. 74 
XI 
